- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04613882
Quantification of the Visual Benefits of Soft Toric Contact Lenses Compared to Soft Spherical Contact Lenses
Quantification of the Visual Benefits of Soft Toric Contact Lenses Compared to Soft Spherical Contact Lenses Over a Range of Refractive Astigmatism
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Manchester, United Kingdom, M13 9PL
- Eurolens Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
-
Subjects will only be eligible for the study if:
- They are of legal age between 18 and 40 years.
- They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
- They are willing and able to follow the protocol.
- They are current wearers of any soft contact lens (i.e. have worn lenses in the last six months).
- They have refractive ocular astigmatism between 0.00DC and -1.50DC in one or both eyes.
- They have a spherical component to their ocular refractive error between 0.00 and - 6.00 DS.
- They could attain at least 0.10 logMAR distance high contrast visual acuity in one eye with the study lenses within the available power range.
- They can be fitted satisfactorily with both lens types.
- They own an acceptable pair of spectacles.
- They agree not to participate in other clinical research for the duration of this study.
Exclusion Criteria:
-
Subjects will not be eligible to take part in the study if:
- They have an ocular disorder which would normally contra-indicate contact lens wear.
- They have a systemic disorder which would normally contra-indicate contact lens wear.
- They are using any topical medication such as eye drops or ointment.
- They have had corneal refractive surgery.
- They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
- They are pregnant or breastfeeding.
- They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.
- They have an amblyopic eye, in which case only dominant eye will be assessed for that subject.
- They have an infectious disease (e.g. hepatitis), any immunosuppressive disease (e.g. HIV) or diabetes.
- They have a history of severe allergic reaction or anaphylaxis.
- They have taken part in any other contact lens clinical trial or research, within two weeks prior to starting this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Soft Toric Custom Made contact lenses
Subjects will be randomized to wear Soft Toric custom made contact lenses for 30 minutes in one eye with other eye patched.
|
Subjects will be randomized to wear soft toric custom made lenses for 30 minutes in one eye with other eye patched.
Subjects will be randomized to wear soft spherical contact lenses for 30 minutes in one eye with other eye patched.
Subjects will be randomized to wear spectacle Correction for 30 minutes in one eye with other eye patched.
|
|
Active Comparator: Soft Spherical Contact Lenses
Subjects will be randomized to wear soft spherical contact lens for 30 minutes in one eye with other eye patched
|
Subjects will be randomized to wear soft toric custom made lenses for 30 minutes in one eye with other eye patched.
Subjects will be randomized to wear soft spherical contact lenses for 30 minutes in one eye with other eye patched.
Subjects will be randomized to wear spectacle Correction for 30 minutes in one eye with other eye patched.
|
|
Active Comparator: Spectacle Correction
Subjects will be randomized to wear spectacle Correction for 30 minutes in one eye with other eye patched.
|
Subjects will be randomized to wear soft toric custom made lenses for 30 minutes in one eye with other eye patched.
Subjects will be randomized to wear soft spherical contact lenses for 30 minutes in one eye with other eye patched.
Subjects will be randomized to wear spectacle Correction for 30 minutes in one eye with other eye patched.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Acuity
Time Frame: Baseline with low contrast VA
|
Visual acuity was assessed using logMAR for each intervention.
|
Baseline with low contrast VA
|
|
Visual Acuity
Time Frame: After 30 minutes of dispense (Low Contrast VA)
|
Visual acuity was assessed using logMAR for each intervention.
|
After 30 minutes of dispense (Low Contrast VA)
|
|
Visual Acuity
Time Frame: Baseline with High contrast VA
|
Visual acuity was assessed using logMAR for each intervention.
|
Baseline with High contrast VA
|
|
Visual Acuity
Time Frame: After 30 minutes of dispense (High Contrast VA)
|
Visual acuity was assessed using logMAR for each intervention.
|
After 30 minutes of dispense (High Contrast VA)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Slit Lamp Biomicroscopy Findings - Conjunctival Redness
Time Frame: Entrance (Prior to wear of study lens)
|
Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is "Entrance" which refers to the time prior to wear of study lens. |
Entrance (Prior to wear of study lens)
|
|
Slit Lamp Biomicroscopy Findings - Conjunctival Redness
Time Frame: At Exit (After 30 minutes in each of three interventions)
|
Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments were done following the removal of the third intervention. Here the time frame used is "Exit" which refers to those measurements taken post-lens/spectacle wear. |
At Exit (After 30 minutes in each of three interventions)
|
|
Slit Lamp Biomicroscopy Findings - Limbal Redness
Time Frame: Entrance (Prior to wear of study lens)
|
Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is "Entrance" which refers to the time prior to wear of study lens. |
Entrance (Prior to wear of study lens)
|
|
Slit Lamp Biomicroscopy Findings - Limbal Redness
Time Frame: At Exit (After 30 minutes in each of three interventions)
|
Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments were done following the removal of the third intervention. Here the time frame used is "Exit" which refers to those measurements taken post-lens/spectacle wear. |
At Exit (After 30 minutes in each of three interventions)
|
|
Slit Lamp Biomicroscopy Findings - Corneal Staining
Time Frame: Entrance (Prior to wear of study lens)
|
Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is "Entrance" which refers to the time prior to wear of study lens. |
Entrance (Prior to wear of study lens)
|
|
Slit Lamp Biomicroscopy Findings - Corneal Staining
Time Frame: At Exit (After 30 minutes in each of three interventions)
|
Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments were done following the removal of the third intervention. Here the time frame used is "Exit" which refers to those measurements taken post-lens/spectacle wear. |
At Exit (After 30 minutes in each of three interventions)
|
|
Slit Lamp Biomicroscopy Findings - Conjunctival Staining
Time Frame: Entrance (Prior to wear of study lens)
|
Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is "Entrance" which refers to the time prior to wear of study lens. |
Entrance (Prior to wear of study lens)
|
|
Slit Lamp Biomicroscopy Findings - Conjunctival Staining
Time Frame: At Exit (After 30 minutes in each of three interventions)
|
Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments were done following the removal of the third intervention. Here the time frame used is "Exit" which refers to those measurements taken post-lens/spectacle wear. |
At Exit (After 30 minutes in each of three interventions)
|
|
Slit Lamp Biomicroscopy Findings - Papillary Conjunctivitis
Time Frame: Entrance (Prior to wear of study lens)
|
Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is "Entrance" which refers to the time prior to wear of study lens. |
Entrance (Prior to wear of study lens)
|
|
Slit Lamp Biomicroscopy Findings - Papillary Conjunctivitis
Time Frame: At Exit (After 30 minutes in each of three interventions)
|
Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments were done following the removal of the third intervention. Here the time frame used is "Exit" which refers to those measurements taken post-lens/spectacle wear. |
At Exit (After 30 minutes in each of three interventions)
|
|
Slit Lamp Biomicroscopy Findings - Corneal Oedema
Time Frame: Entrance (Prior to wear of study lens)
|
Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments done were recorded prior to the first intervention. Here the time frame used is "Entrance" which refers to the time prior to wear of study lens. |
Entrance (Prior to wear of study lens)
|
|
Slit Lamp Biomicroscopy Findings - Corneal Oedema
Time Frame: At Exit (After 30 minutes in each of three interventions)
|
Slit lamp Biomicroscopy findings were assessed on Efron Grading scales scored to the nearest 0.1 on a scale of 0 - 4 (0=normal, 1=trace, 2=mild, 3=moderate, 4=severe). The assessments were done following the removal of the third intervention. Here the time frame used is "Exit" which refers to those measurements taken post-lens/spectacle wear. |
At Exit (After 30 minutes in each of three interventions)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael Read, Eurolens Research
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- C19-683 (EX-MKTG-116)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
London Vision ClinicOptana GmbHActive, not recruitingCorneal AstigmatismUnited Kingdom
-
Eye Hospital Pristina KosovoActive, not recruiting
-
Yonsei UniversityUnknownMyopic AstigmatismKorea, Republic of
-
Abbott Medical OpticsCompletedRefractive AstigmatismAustria
-
Ziemer Ophthalmic Systems AGTigermed Consulting Co., LtdRecruitingMyopic AstigmatismChina
-
Bausch & Lomb IncorporatedCompleted
-
CooperVision, Inc.CompletedAstigmatism BilateralCanada
-
University Clinic FrankfurtCompleted
Clinical Trials on Soft Toric Custom Made Contact lens
-
University of Alabama at BirminghamWithdrawnRefractive Errors | Myopia
-
Ohio State UniversityCompletedAstigmatism BilateralUnited States
-
Indonesia UniversityCompletedVisual Acuity Reduced TransientlyIndonesia
-
University of WaterlooCIBA VISIONCompleted
-
CooperVision, Inc.CompletedAstigmatism | MyopiaUnited Kingdom
-
Alcon ResearchWithdrawnRefractive Errors | AstigmatismUnited States
-
Johnson & Johnson Vision Care, Inc.Johnson & JohnsonTerminatedRefractive Error | Astigmatism | MyopiaJapan
-
Alcon ResearchCompletedRefractive Error | Astigmatism | Myopia
-
CooperVision, Inc.Completed
-
FORSIGHT Vision3Completed